Live
Forbes 30 Under 30 star could be jailed for 52 yearsSkinBioTherapeutics share price crashes as ex-CEO investigatedListed Rosebank eyes £3bn double swoopForbes 30 Under 30 star could be jailed for 52 yearsSkinBioTherapeutics share price crashes as ex-CEO investigatedListed Rosebank eyes £3bn double swoop
Latest Stories
Listed Rosebank eyes £3bn double swoop
Firm led by former Melrose chief executive Simon Peckham made first acquisition late last year and is now eyeing two more
Yorkshire life sciences firm impacted by ‘mistaken assumptions’
ProBiotix Health plc says falling share price is result of events at SkinBioTherapeutics plc which ‘have no bearing whatsoever on us’
Optima Health to buy PAM Healthcare in £100m deal
Acquisition is part of Optima’s strategy to hit £200m revenue and the deal will signal an exit for private equity investor LDC
News, views, reports and more from the UK tech scene - delivered to your inbox at 9am every morning
More News
Forbes 30 Under 30 star could be jailed for 52 yearsSkinBioTherapeutics share price crashes as ex-CEO investigatedListed Rosebank eyes £3bn double swoopPinewood share price nosedives as £575m takeover falls throughYorkshire life sciences firm impacted by ‘mistaken assumptions’Optima Health to buy PAM Healthcare in £100m dealBusinessBite: US giant ‘pumps £150m into debt-laden Very Group’Leeson and Brown to close Blank Space Content StudioSkinBioTherapeutics accuses former CEO of misrepresenting resultsMedpal acquires Universal Pharmacy assets out of administrationVote in our EdTech 50 innovation rankingCandy’s Cupcakes founder’s journey from home kitchen to £2m turnoverUK’s 46 FinTech unicorns revealedNscale signs £1bn loan to build more AI data centresSkinBioTherapeutics CEO resigns over conductAdmiral Group drives away with InsurTech in £80m deal